Federal Register / Vol. 76, No. 237 / Friday, December 9, 2011 / Notices 76981 

SES Non-SES 

Catherine Beck Bernadette Dunham 

Susan Bernard Ted Elkin 

Malcolm Bertoni Jeff Farrar 

Eric Blumberg William Flynn 

Beverly 

Chernaik 

Christy Foreman 

Dara Corrigan Malcolm Frazier 

Kathleen Crosby Alberto Gutierrez 

L’Tonya Davis Sheryl Lard-Whiteford 

David Elder Murray Lumpkin 

Denise Esposito William Maisel 

Tracy Forfa Karen Midthun 

Lillian Gill Ellen Morrison 

Deborah Henderson Steven Musser 

Kimberly Holden Steven Pollack 

Jeanne Ireland Jonathan Sackner-Bernstein 

Melanie Keller Barbara Schneeman 

Michael Landa Rachel Sherman 

Caroline Lewis Jeffrey Shuren 

Eric Lindblom Ann Simoneau 

Mary Anne Malarkey William Slikker 

Diane Maloney Steven Solomon 

Daniel 

McChesney 

Stephen Spielberg 

William 

McConagha 

Roberta Wagner 

Patrick McGarey David White 

Ruth McKee Carolyn Wilson 

Alfred R. Miller Janet Woodcock 

Theresa Mullin Robert Yetter 

Deanna Murphy Donald Zink 

Melinda Plaisier 

Lynne Rice 

Mark Roh 

James Sigg 

Steven Silverman 

Howard 

Sklamberg 

Philip Spiller 

Nancy Stade 

John Taylor 

Michael Taylor 

Brian Trent 

Mary Lou 

Valdez 

Steven Vaughn 

Stephen 

Veneruso 

Helen Winkle 

Ann Wion 

Dated: December 1, 2011. 

Margaret A. Hamburg, 

Commissioner of Food and Drugs. 

[FR Doc. 2011–31579 Filed 12–8–11; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, NCI SPORE 

in Prostate and Gastrointestinal Cancers. 

Date: February 15–16, 2012. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, Montgomery County 

Conference Center Facility, 5701 Marinelli 

Road, North Bethesda, MD 20852. 

Contact Person: Caron A Lyman, PhD, 

Scientific Review Officer, National Cancer 

Institute, NIH, Division of Extramural 

Activities, Research Programs Review 

Branch, 6116 Executive Blvd., Room 8119, 

Bethesda, MD 20892–8328, (301) 451–4761, 

lymanc@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, 

International Tobacco and Health Research 

and Capacity Building Program. 

Date: February 28–29, 2012. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Gerald G. Lovinger, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Blvd., Room 8055A, 

Bethesda, MD 20892–8329, (301) 496–7987, 

lovingeg@mail.nih.gov. 

Name of Commitee: National Cancer 

Institute Special Emphasis Panel, Small 

Grants Program for Cancer Epidemiology. 

Date: March 22–23, 2012. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, Montgomery County 

Conference Center Facility, 5701 Marinelli 

Road, North Bethesda, MD 20852. 

Contact Person: Jeffrey E. DeClue, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Boulevard, Room 8059, 

Bethesda, MD 20892–8329, (301) 496–7904, 

decluej@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, 

Nanotechnology Reformulations for Cancer 

Drugs. 

Date: April 12, 2012. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Bethesda North Marriott Hotel & 

Conference Center, Montgomery County 

Conference Center Facility, 5701 Marinelli 

Road, North Bethesda, MD 20852. 

Contact Person: Jeffrey E. DeClue, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Boulevard, Room 8059, 

Bethesda, MD 20892–8329, (301) 496–7904, 

decluej@mail.nih.gov. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

deainfo.nci.nih.gov/advisory/sep/sep.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: December 5, 2011. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–31679 Filed 12–8–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

[Docket No. DHS–2011–0115] 

Request for Public Comments 

Concerning U.S.-Canada Action Plan 

for Perimeter Security and Economic 

Competitiveness 

AGENCY: Office of Policy, DHS. 

ACTION: Notice. 

SUMMARY: The United States and Canada 

are staunch allies, vital economic 

partners, neighbors, and steadfast 

friends. We share common values, 

communities, and deep links among our 

citizens. The extensive mobility of 

people, goods, capital, and information 

between our two countries has helped 

ensure that our societies remain open, 

democratic, prosperous, and secure. 

On February 4, 2011, President Barack 

Obama and Canadian Prime Minister 

Stephen Harper announced Beyond the 

Border: A Shared Vision for Perimeter 

Security and Economic 

Competitiveness. This declaration 

describes a perimeter approach to 

security in which the United States and 

Canada share responsibility for the 

security and resilience of our nations. 


srobinson on DSK4SPTVN1PROD with NOTICES
76982 Federal Register / Vol. 76, No. 237 / Friday, December 9, 2011 / Notices 

Our countries will seek to jointly 

address threats at the earliest point 

possible, while working together to 

facilitate the flows of legitimate travel 

and trade. 

Beyond the Border identifies four key 

areas of cooperation: Addressing 

Threats Early; Trade Facilitation, 

Economic Growth, and Jobs; Integrated 

Cross-Border Law Enforcement; and 

Critical Infrastructure and 

Cybersecurity. Progress in these areas 

will be underpinned by a respect for the 

sovereignty, civil rights and civil 

liberties, privacy protections, and legal 

frameworks of both countries. 

On December 7, 2011, President 

Barack Obama and Prime Minister 

Harper announced the Beyond the 

Border Action Plan, which describes 

specific initiatives our countries intend 

to undertake to achieve Beyond the 

Border’s goals of perimeter security and 

economic competitiveness. With this 

notice, the United States Department of 

Homeland Security (DHS), on behalf of 

the Administration, is seeking public 

input on the Beyond the Border Action 

Plan. 

DATES: The agency must receive 

comments on or before January 9, 2012. 

ADDRESSES: Interested parties are 

invited to submit comments on the BTB 

Action Plan. You may submit 

comments, identified by the docket 

number DHS–2011–0115 through the 

Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the 

instructions for submitting comments. 

Electronic comment submissions 

should be emailed to 

BeyondtheBorder@hq.dhs.gov. Please 

direct written submissions to Beyond 

the Border Coordinator, U.S. 

Department of Homeland Security, 

Mailstop 0455, Washington, DC 20016. 

The public is strongly encouraged to file 

submissions electronically rather than 

by mail. 

FOR FURTHER INFORMATION CONTACT: 

BeyondtheBorder@hq.dhs.gov or visit 

http://www.dhs.gov/files/publications/ 

beyond-the-border.shtm. 

SUPPLEMENTARY INFORMATION: None. 

Requirements for Submissions: In 

order to ensure the timely receipt and 

consideration of comments, the White 

House and DHS strongly encourage 

commenters to make submissions via 

email to BeyondtheBorder@hq.dhs.gov. 

For any comments submitted 

electronically containing business 

confidential information, the file name 

of the business confidential version 

should begin with the characters ‘‘BC’’. 

The top of any page containing business 

confidential information must clearly be 

marked ‘‘BUSINESS CONFIDENTIAL’’. 

Any person filing comments that 

contain business confidential 

information must also file in a separate 

submission a public version of the 

comments. The file name of the public 

version of the comments should begin 

with the character ‘‘P’’. The ‘‘BC’’ and 

‘‘P’’ should be followed by the name of 

the person or entity submitting the 

comments. If a comment contains no 

business confidential information, the 

file name should begin with the 

character ‘‘P’’, followed by the name of 

the person or entity submitting 

comments. 

Please do not attach separate cover 

letters to electronic submissions; rather, 

include any information that might 

appear in a cover letter in the comments 

themselves. Similarly, to the extent 

possible, please include any exhibits, 

annexes, or other attachments in the 

same file as the submission itself, not as 

separate files. 

Luis Alvarez, 

Deputy Assistant Secretary for International 

Affairs. 

[FR Doc. 2011–31598 Filed 12–8–11; 8:45 am] 

BILLING CODE 9110–9L–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Citizenship and Immigration 

Services 

Agency Information Collection 

Activities: Form I–130, Extension of a 

Currently Approved Information 

Collection; Comment Request 

ACTION: 30-Day Notice of Information 

Collection Under Review: Form I–130, 

Petition for Alien Relative. 

The Department of Homeland 

Security, U.S. Citizenship and 

Immigration Services (USCIS) will be 

submitting the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and clearance in accordance 

with the Paperwork Reduction Act of 

1995. An information collection notice 

was published in the Federal Register 

on September 30, 2011, at 76 FR 60852, 

allowing for a 60-day public comment 

period. USCIS did not receive any 

comments in connection with that 

notice. 

The purpose of this notice is to allow 

an additional 30 days for public 

comments. Comments are encouraged 

and will be accepted until January 9, 

2012. This process is conducted in 

accordance with 5 CFR 1320.10. 

Written comments and/or suggestions 

regarding any item contained in this 

notice, especially those regarding the 

estimated public burden and associated 

response time, should be directed to the 

Department of Homeland Security 

(DHS), and to the Office of Management 

and Budget (OMB) USCIS Desk Officer. 

Comments may be submitted to: USCIS, 

Chief, Regulatory Products Division, 20 

Massachusetts Avenue, Washington, DC 

20529–2020. Comments may also be 

submitted to DHS via facsimile to (202) 

272–8352 or via email at 

uscisfrcomment@dhs.gov, and to the 

OMB USCIS Desk Officer via facsimile 

at (202) 395–5806 or via email at 

oira_submission@omb.eop.gov. When 

submitting comments by email please 

make sure to add OMB Control Number 

1615–0012 in the subject box. Written 

comments and suggestions from the 

public and affected agencies should 

address one or more of the following 

four points: 

(1) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(2) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(3) Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

(4) Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

(1) Type of Information Collection: 

Extension of a currently approved 

information collection. 

(2) Title of the Form/Collection: 

Petition for Alien Relative. 

(3) Agency form number, if any, and 

the applicable component of the 

Department of Homeland Security 

sponsoring the collection: Form I–130; 

U.S. Citizenship and Immigration 

Services (USCIS). 

(4) Affected public who will be asked 

or required to respond, as well as a brief 

abstract: Primary: Individuals or 

Households. This form allows citizens 

or lawful permanent residents of the 

United States to petition on behalf of 

certain alien relatives who wish to 

immigrate to the United States. 


srobinson on DSK4SPTVN1PROD with NOTICES